In vitro uses of human pluripotent stem cell-derived cardiomyocytes.

Abstract

Functional cardiomyocytes can be efficiently derived from human pluripotent stem cells (hPSCs), which collectively include embryonic and induced pluripotent stem cells. This cellular platform presents exciting new opportunities for development of pharmacologically relevant in vitro screens to detect cardiotoxicity, validate novel drug candidates in… (More)

Topics

Cite this paper

@article{Matsa2012InVU, title={In vitro uses of human pluripotent stem cell-derived cardiomyocytes.}, author={Elena Matsa and Chris N. Denning}, journal={Journal of cardiovascular translational research}, year={2012}, volume={5 5}, pages={581-92} }